Skip to main content
. 2021 Mar 17;64(1):e21. doi: 10.1192/j.eurpsy.2021.13
Grade Recommendation
C If a patient with negative symptoms shows extrapyramidal and/or sedative side effects, a reduction of the antipsychotic dose or a switch to an antipsychotic with lower risk for extrapyramidal and/or sedative side effects can be considered.